The impact of metabolic syndrome on long‐term outcomes of percutaneous nephrolithotomy (PCNL)

Abstract

• The most frequent stone type was calcium oxalate monohydrate in patients with or without metabolic syndrome. • In patients with metabolic syndrome who underwent PCNL, the stone recurrence rate was >40%. • Metabolic syndrome is associated with worsening renal function at long-term follow-up.